Abintus Bio, Inc.

Abintus Bio, Inc. is a San Diego-based, preclinical stage gene therapy company focused on the discovery and development of a portfolio of product candidates that are designed to directly reprogram immune cells from within their native environment, using proprietary vectors and related technologies.

Overview Structured Data Issues Contributors

abintusbio.com

Is a

Organization

Company

Company attributes

Industry

‌

CAR T-Cell therapy

Biomedical engineering

...

Location

B2X

CEO

Founder

Date Incorporated

2020

Number of Employees (Ranges)

11 – 50

Email Address

info@abintus.com

applications@abintus.com

info@abintusbio.com

Full Address

10355 Science Center Dr Ste 250 San Diego, CA, 92121-1158 United States

CIK Number

1,942,876

Investors

‌

Skyviews Life Sciences

Founded Date

2020

Total Funding Amount (USD)

15,652,623

Latest Funding Round Date

August 15, 2022

Latest Funding Type

Convertible note

Country

United States

Other attributes

Company Operating Status

Active

Latest Funding Round Amount (USD)

15,652,623

Abintus Bio, Inc. is a preclinical stage gene therapy company that focuses on discovering and developing a portfolio of product candidates that are designed to directly reprogram immune cells from their native environment using proprietary vectors.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Abintus Bio, Inc.

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.